N/A
Completed N=52
Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion
Nasal Congestion and Inflammations
Source: ClinicalTrials.gov NCT05821842 ↗
Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Primary Effectiveness — -0.87; -0.44 score on a scale
Summary
To demonstrate the safety and effectiveness of Sonu for the treatment of patients suffering from moderate to severe nasal congestion.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Primary Effectiveness |
-0.87; -0.44 | — |
| SECONDARY Secondary Effectiveness |
-2.85; -1.32 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years of age and older
- Present with symptoms of nasal congestion for 1 month or more prior to treatment
- Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening
Exclusion Criteria
- Head, nasal or sinus surgery within 3 months
- Sinus infection diagnosed within the last month, or rhinitis medicamentosa
- Documented history of nasal polyposis or mass
Data sourced from ClinicalTrials.gov (NCT05821842). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.